CAS: 170277-31-3 - Immunoglobulin G, anti-(human tumor necrosis factor), (human-mouse monoclonal cA2 heavy chain), disulfide with human-mouse monoclonal cA2 light chain, dimer
Fórmula:Unspecified
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | Infliximab CRS REF: 41-Y0002047CAS: 170277-31-3 | - - - | 115,00 € | Mar 07 May 24 |
 | Infliximab REF: TM-T9921CAS: 170277-31-3 | 99.70% | A consultar | Jue 16 May 24 |
 | Infliximab (10 mg/ml) REF: 3D-FI139130CAS: 170277-31-3 | Min. 95% | 477,00 €~1.829,00 € | Mar 21 May 24 |
Ref: 41-Y0002047
| 100mg | 115,00 € |
Entrega estimada en Estados Unidos, el Martes 7 de Mayo de 2024
Infliximab
CAS:170277-31-3
Infliximab is a humanized antibody against tumor necrosis factor α TNF-α) that is used in …
Pureza:
99.70%
Forma y color:
Solid
Peso molecular:
149 kDa
Ref: TM-T9921
| 1mg | 95,00 € | |
| 2mg | 157,00 € | |
| 5mg | 254,00 € | |
| 10mg | 369,00 € | |
| 25mg | 618,00 € | |
| 50mg | 878,00 € | |
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Jueves 16 de Mayo de 2024
Infliximab (10 mg/ml)
CAS:170277-31-3
Infliximab is a chimeric monoclonal antibody against tumor necrosis factor-alpha (TNF-α). It binds to the …
Pureza:
Min. 95%
Forma y color:
Powder
Ref: 3D-FI139130
| 5mg | 477,00 € | |
| 10mg | 595,00 € | |
| 25mg | 810,00 € | |
| 50mg | 1.219,00 € | |
| 100mg | 1.829,00 € |
Entrega estimada en Estados Unidos, el Martes 21 de Mayo de 2024
